Neuroproteomics – the tasks lying ahead

Abstract

The brain is unquestionably the most fascinating organ. Despite tremendous progress, current knowledge falls short of being able to explain its function. An emerging approach toward improved understanding of the molecular mechanisms underlying brain function is neuroproteomics. Today's neuroscientists have access to a battery of versatile technologies both in transcriptomics and proteomics. The challenge is to choose the right strategy in order to generate new hypotheses on how the brain works. The goal of this review is therefore two-fold: first we recall the bewildering cellular, molecular, and functional complexity in the brain, as this knowledge is fundamental to any study design. In fact, an impressive complexity on the molecular level has recently re-emerged as a central theme in large-scale analyses. Then we review transcriptomics and proteomics technologies, as both are complementary. Finally, we comment on the most widely used proteomics techniques and their respective strengths and drawbacks. We conclude that for the time being, neuroproteomics should focus on its strengths, namely the identification of posttranslational modifications and protein-protein interactions, as well as the characterization of highly purified subproteomes. For global expression profiling, emphasis should be put on further development to significantly increase coverage.

Differential Proteomics of the Cerebral Cortex of Juvenile, Adult and Aged Rats: An Ontogenetic Study

“…As shown in Figure 2, it is observable that especially the lateral parts of the gels show a lower resolution than the central parts which can lead to a possible misinterpretation of the regulation analysis of some protein spots. Therefore, it is possible to analyze a major part, but not the entire proteome of the Cx [36]. Additionally, it has to be mentioned that no analysis of enzyme activity was performed in this study.…”

A review of current applications of mass spectrometry for neuroproteomics in epilepsy

“…Numerous different histological regions, defined nuclei, subnuclei, and neuronal clusters can be distinguished, together with an immense number of connections and circuits. For many of these structures, specialized functions have been demonstrated that are reflected in the anatomical layout or molecular repertoire (Becker, Schindler, & Nothwang, 2006). Functional and structural heterogeneity continues on the cellular level.…”

Post-Genomics Nanotechnology Is Gaining Momentum: Nanoproteomics and Applications in Life Sciences

“…The rapidly growing field of proteomics has excelled in several disciplines in biology, including injury, cancer, aging, and different neurological conditions, as well as psychiatric conditions including drug/substance abuse, schizophrenia, and depression (Abul-Husn and Devi, 2006;Becker et al, 2006;Becker, 2006;Choudhary and Grant, 2004;Cochran et al, 2003;Dean and Overall, 2007;Dumont et al, 2004). Proteomics is one of the fastest growing fields of biochemical sciences; a PubMed search reveals 287,021 articles published in the past 2 years containing the word ''protein,'' compared to 156,200 articles using the term ''gene'' ( January, 2011-April, 2013, which may also reflect a shift in genomics studies towards proteomics investigations.…”